BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19161428)

  • 1. Regulation of immune responses by interleukin-27.
    Yoshida H; Miyazaki Y
    Immunol Rev; 2008 Dec; 226():234-47. PubMed ID: 19161428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune regulation by IL-27 for therapeutic usage].
    Yoshida H
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Aug; 32(4):202-13. PubMed ID: 19721340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 27: a double-edged sword for offense and defense.
    Yoshida H; Nakaya M; Miyazaki Y
    J Leukoc Biol; 2009 Dec; 86(6):1295-303. PubMed ID: 19801497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
    Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
    Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 27 signaling pathways in regulation of immune and autoimmune responses.
    Yoshida H; Miyazaki Y
    Int J Biochem Cell Biol; 2008; 40(11):2379-83. PubMed ID: 18588993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited.
    Boniface K; Blom B; Liu YJ; de Waal Malefyt R
    Immunol Rev; 2008 Dec; 226():132-46. PubMed ID: 19161421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
    Stadhouders R; Lubberts E; Hendriks RW
    J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders.
    Gee K; Guzzo C; Che Mat NF; Ma W; Kumar A
    Inflamm Allergy Drug Targets; 2009 Mar; 8(1):40-52. PubMed ID: 19275692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Th1 and Th17 cells in organ-specific autoimmunity.
    Dardalhon V; Korn T; Kuchroo VK; Anderson AC
    J Autoimmun; 2008 Nov; 31(3):252-6. PubMed ID: 18502610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders.
    Goriely S; Cavoy R; Goldman M
    Allergy; 2009 May; 64(5):702-9. PubMed ID: 19383026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-23/IL-17 biology and therapeutic considerations.
    Dong C
    J Immunotoxicol; 2008 Jan; 5(1):43-6. PubMed ID: 18382857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17.
    Rangachari M; Mauermann N; Marty RR; Dirnhofer S; Kurrer MO; Komnenovic V; Penninger JM; Eriksson U
    J Exp Med; 2006 Aug; 203(8):2009-19. PubMed ID: 16880257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation.
    Böhme J; Roßnagel C; Jacobs T; Behrends J; Hölscher C; Erdmann H
    Immunology; 2016 Mar; 147(3):338-48. PubMed ID: 26694585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
    Sonderegger I; Kisielow J; Meier R; King C; Kopf M
    Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment.
    Takeda A; Hamano S; Yamanaka A; Hanada T; Ishibashi T; Mak TW; Yoshimura A; Yoshida H
    J Immunol; 2003 May; 170(10):4886-90. PubMed ID: 12734330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity.
    Shinozaki Y; Wang S; Miyazaki Y; Miyazaki K; Yamada H; Yoshikai Y; Hara H; Yoshida H
    Int J Cancer; 2009 Mar; 124(6):1372-8. PubMed ID: 19089917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice.
    Miyazaki Y; Inoue H; Matsumura M; Matsumoto K; Nakano T; Tsuda M; Hamano S; Yoshimura A; Yoshida H
    J Immunol; 2005 Aug; 175(4):2401-7. PubMed ID: 16081811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.